Skip to main content

Premier Partners — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

80
Companies
$1.4B
Total invested
$24.0M
Avg. check
53
Industries
Health Care 11Biotechnology 8Artificial Intelligence (AI) 6Medical 5Information Technology 4Software 4+47 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 124 of 80
Nventric
June 2026

Nventric is a medical device company that develops core products for neurovascular, coronary heart, and peripheral vascular applications.

Medical Device · Arcadia$22.6M Venture - Series Unknown
Neumora Therapeutics
April 2024

Neumora Therapeutics operates as a clinical-stage biotechnology company.

Biotechnology · Watertown$2.6M Grant
MangoBoost
April 2026

MangoBoost architects next-generation AI infrastructure for the agentic AI era

Agentic AI · Bellevue$6.7M Series B
Upstage
August 2025

Upstage is an AI-driven language models and document processing engines that streamline data extraction, analysis, and workflow management.

Artificial Intelligence (AI) · Yongin$44.6M Series B
Celltrio
June 2025

Celltrio is a manufacturer of cell culturing automation and biobanking solutions.

Information Technology · Fremont$15.0M Venture - Series Unknown
AIRS Medical
March 2025

AIRS Medical is an MRI reconstruction software service provider.

Health Care · Doksansadong$3K Venture - Series Unknown
Healing Paper
February 2025

Healing Paper uses ICT to improve medical service access, reduce costs, and balance information between experts and non-experts.

Beauty · Seocho$29.7M Series C
Stars Tech
May 2024

Stars tech is a eco-friendly snow removal agent using starfish extract.

Chemical · Seoul$11.0M Series C
Cupix
May 2024

Cupix is delivering the industry's most flexible and easiest to deploy 3D digital twin platform to builders and owners everywhere.

Computer Vision · San Jose$40.0M Series C
Aardvark Therapeutics
May 2024

Aardvark Therapeutics specializes in small molecule therapeutics for obesity and rare genetic metabolic disorders.

Biotechnology · San Diego$85.0M Series C
Kanaph Therapeutics
December 2023

Kanaph Therapeutics is a leading biotech in oncology, auto-immune, and eye diseases with large molecules and small molecules.

Biotechnology · Yongsan$17.8M Series C
Gbike
December 2023

Gbike is a personal Smart Mobility Sharing Platform.

Cycling · Seoul$9.1M Series C
Cafe24
December 2023

Cafe24 is a global e-commerce platform that provides everything you need to build an online DTC store in one-stop.

Consulting · Seoul$19.8M Venture - Series Unknown
Medipixel
October 2023

Medipixel is a healthcare technology company that has created a number of AI-enhanced solutions for intervention surgeons.

Artificial Intelligence (AI) · Seoul$12.6M Series B
Saige Research
September 2023

Saige Research specializes in artificial intelligence solutions for industrial inspection and quality control.

Artificial Intelligence (AI) · Seoul$11.6M Series B
Endorobotics
August 2023

Endorobotics is a healthcare centre that offers endoscopic surgery services.

Health Care · Seoul$7.5M Series B
Moloco
June 2023

Moloco offers programmatic advertising solutions to help optimize the client's acquisition, retention, and monetization campaigns.

Advertising · Redwood City$24.2M Series D
AITRICS
December 2025

AITRICS delivers AI-powered medical software designed to support clinicians in detecting and preventing critical patient deterioration.

Analytics · Seoul$23.8M Series C
Connext
March 2026

Connext is developing biological therapeutics in the field of immuno-oncology and regenerative medicine.

Biotechnology · Daegu$10.0M Series C
Orum Therapeutics
December 2025

Private biotech company creating cell penetrating therapeutic antibodies

Biotechnology · Daejeon$98.3M Post Ipo Equity
MicrobiotiX
August 2025

MicrobiotiX develops bacteriophage and microbiome-based therapeutics to combat multidrug-resistant infections and autoimmune diseases.

Biotechnology · Seoul$3.6M Series B
AIGEN Sciences
July 2025

AIGEN Sciences is an AI drug discovery platform that provides drug research and development services.

Artificial Intelligence (AI) · SeoulSeries Unknown
Medisolar
April 2025

Medisolar, a customized food care solution company

Health Care · Hannamiltong$9.0M Series A
Prazer Therapeutics
April 2025

Prazer Therapeutics is a biotechnology company that generates novel therapeutics for refractory diseases.

Biotechnology · Seoul$19.7M Series B

Where Premier Partners invests

Health Care11
Biotechnology8
Artificial Intelligence (AI)6
Medical5
Information Technology4
Software4

About Premier Partners's portfolio

How many companies has Premier Partners invested in?

Premier Partners has invested in 80 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Premier Partners invest in?

Premier Partners's top investment sectors include Health Care, Biotechnology, Artificial Intelligence (AI), Medical, Information Technology. The firm invests across 53 different industry categories.

What is Premier Partners's largest investment?

Among tracked funding rounds, Orum Therapeutics received $98.3M in a Post Ipo Equity round. Premier Partners's total known invested capital is $1.4B.

What is the average investment size for Premier Partners?

Premier Partners's average investment size is $24.0M across its portfolio of 80 companies.

What are Premier Partners's most recent investments?

Recent Premier Partners portfolio additions include Nventric, Neumora Therapeutics, MangoBoost, Upstage, Celltrio. These companies were founded in 2020 or later.

Reach the founders behind these 80 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →